BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 8126064)

  • 1. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE; Blasi F; Rifkin DB
    J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
    J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
    Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
    J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of retinoid-induced activation of latent transforming growth factor-beta in bovine endothelial cells.
    Kojima S; Rifkin DB
    J Cell Physiol; 1993 May; 155(2):323-32. PubMed ID: 8482724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of latent TGF-beta activation by murine peritoneal macrophages.
    Nunes I; Shapiro RL; Rifkin DB
    J Immunol; 1995 Aug; 155(3):1450-9. PubMed ID: 7636210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity.
    Odekon LE; Sato Y; Rifkin DB
    J Cell Physiol; 1992 Feb; 150(2):258-63. PubMed ID: 1734031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A; Tredget EE; Shen Q
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
    Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
    Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
    Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK
    Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis.
    Brauer PR; Yee JA
    Dev Biol; 1993 Jan; 155(1):281-5. PubMed ID: 8416842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M; Miyazaki H; Kojima S
    J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
    Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
    J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
    Yue J; Sun B; Liu G; Mulder KM
    J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic activation of latent TGF-beta precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells.
    Solovyan VT; Keski-Oja J
    J Cell Physiol; 2006 May; 207(2):445-53. PubMed ID: 16447253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of transforming growth factor-beta isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation.
    Slager HG; Freund E; Buiting AM; Feijen A; Mummery CL
    J Cell Physiol; 1993 Aug; 156(2):247-56. PubMed ID: 8344983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion.
    Albo D; Berger DH; Tuszynski GP
    J Surg Res; 1998 Apr; 76(1):86-90. PubMed ID: 9695745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiostatic role of astrocytes: suppression of vascular endothelial cell growth by TGF-beta and other inhibitory factor(s).
    Behzadian MA; Wang XL; Jiang B; Caldwell RB
    Glia; 1995 Dec; 15(4):480-90. PubMed ID: 8926041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.